225 related articles for article (PubMed ID: 19904262)
1. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.
Yokota N; Koizume S; Miyagi E; Hirahara F; Nakamura Y; Kikuchi K; Ruf W; Sakuma Y; Tsuchiya E; Miyagi Y
Br J Cancer; 2009 Dec; 101(12):2023-9. PubMed ID: 19904262
[TBL] [Abstract][Full Text] [Related]
2. High-level secretion of tissue factor-rich extracellular vesicles from ovarian cancer cells mediated by filamin-A and protease-activated receptors.
Koizume S; Ito S; Yoshioka Y; Kanayama T; Nakamura Y; Yoshihara M; Yamada R; Ochiya T; Ruf W; Miyagi E; Hirahara F; Miyagi Y
Thromb Haemost; 2016 Jan; 115(2):299-310. PubMed ID: 26446354
[TBL] [Abstract][Full Text] [Related]
3. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y
Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600
[TBL] [Abstract][Full Text] [Related]
4. Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O₂ and Plasma Supply.
Koizume S; Miyagi Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417928
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol Starvation and Hypoxia Activate the FVII Gene via the SREBP1-GILZ Pathway in Ovarian Cancer Cells to Produce Procoagulant Microvesicles.
Koizume S; Takahashi T; Yoshihara M; Nakamura Y; Ruf W; Takenaka K; Miyagi E; Miyagi Y
Thromb Haemost; 2019 Jul; 119(7):1058-1071. PubMed ID: 31055798
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism.
Ma Z; Zhang T; Wang R; Cheng Z; Xu H; Li W; Wang Y; Wang X
Int J Gynecol Cancer; 2011 May; 21(4):616-24. PubMed ID: 21543928
[TBL] [Abstract][Full Text] [Related]
7. Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner.
Edén D; Panagiotou G; Mokhtari D; Eriksson JW; Åberg M; Siegbahn A
Ups J Med Sci; 2019 Aug; 124(3):158-167. PubMed ID: 31407948
[No Abstract] [Full Text] [Related]
8. III. Instantaneous inhibition by compound 48/80 of tissue factor-initiated extrinsic coagulation is mediated by the downregulation of factor VII activation.
Chu AJ; Wang ZG; Fox MJ
Arch Biochem Biophys; 2000 May; 377(2):357-65. PubMed ID: 10845714
[TBL] [Abstract][Full Text] [Related]
9. Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis.
Tang JQ; Fan Q; Wu WH; Jia ZC; Li H; Yang YM; Liu YC; Wan YL
Chin Med J (Engl); 2010 Dec; 123(24):3559-65. PubMed ID: 22166631
[TBL] [Abstract][Full Text] [Related]
10. Tissue Factor-Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes.
Koizume S; Miyagi Y
Biomark Cancer; 2015; 7(Suppl 2):1-13. PubMed ID: 26396550
[TBL] [Abstract][Full Text] [Related]
11. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor pathway.
McVey JH
Baillieres Best Pract Res Clin Haematol; 1999 Sep; 12(3):361-72. PubMed ID: 10856975
[TBL] [Abstract][Full Text] [Related]
13. Determination of the kinetic constants of tissue factor/factor VII/factor VIIA and antithrombin/heparin using surface plasmon resonance.
Björquist P; Boström S
Thromb Res; 1997 Feb; 85(3):225-36. PubMed ID: 9058497
[TBL] [Abstract][Full Text] [Related]
14. Structural requirements for the interaction between tissue factor and factor VII: characterization of chymotrypsin-derived tissue factor polypeptides.
O'Brien DP; Anderson JS; Martin DM; Byfield PG; Tuddenham EG
Biochem J; 1993 May; 292 ( Pt 1)(Pt 1):7-12. PubMed ID: 8503864
[TBL] [Abstract][Full Text] [Related]
15. Consumption of plasma factor VII in a rabbit model of non-overt disseminated intravascular coagulation.
Clarke BJ; Sridhara S; Woskowska Z; Blajchman MA
Thromb Res; 2002 Dec; 108(5-6):329-34. PubMed ID: 12676194
[TBL] [Abstract][Full Text] [Related]
16. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa.
Reuning U; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434
[TBL] [Abstract][Full Text] [Related]
17. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor up-regulation in proinflammatory conditions confers thrombin generation capacity to endothelial colony-forming cells without influencing non-coagulant properties in vitro.
Cuccuini W; Poitevin S; Poitevin G; Dignat-George F; Cornillet-Lefebvre P; Sabatier F; Nguyen P
J Thromb Haemost; 2010 Sep; 8(9):2042-52. PubMed ID: 20546120
[TBL] [Abstract][Full Text] [Related]
19. [Ectopic expression and clinical significance of tissue factor/coagulation factor VII complex in colorectal cancer].
Tang JQ; Fan Q; Wan YL; Liu YC; Wang X; Wu T; Pan YS; Wu WH; Zhu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):531-6. PubMed ID: 19829668
[TBL] [Abstract][Full Text] [Related]
20. A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates.
Toso R; Pinotti M; High KA; Pollak ES; Bernardi F
Biochem J; 2002 Apr; 363(Pt 2):411-6. PubMed ID: 11931672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
